¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ¼öÁ¤ »èÁ¦

´ëÇÑÁ¾¾ç³»°úÇÐȸ Best of San Antonio Breast Cancer Symposium (SABCS) 2021 in Korea : 2022-01-29

ÃßõÇϱâ
¿¬¼ö°­Á À̹øÁÖ BEST
 
´ëÇÑÁ¾¾ç³»°úÇÐȸ Best of San Antonio Breast Cancer Symposium (SABCS) 2021 in Korea : 2022-01-29
±³À°ÀÏÀÚ : 2022-01-29
±³À°Àå¼Ò : ¼­¿ïµå·¡°ï½ÃƼ ÇѶó  
±³À°ÁÖÁ¦ : Best of San Antonio Breast Cancer Symposium (SABCS) 2021 in Korea
ÁÖÃÖ±â°ü : ´ëÇÑÁ¾¾ç³»°úÇÐȸ(17.5 ¸íĪº¯°æ Çѱ¹ÀÓ»ó¾ÏÇÐȸ)
´ã´çÀÚ : ´ëÇÑÁ¾¾ç³»°úÇÐȸ
¿¬¶ôó : 02-735-2857  
À̸ÞÀÏ : meetings@ksmo.or.kr      
±³À°Á¾·ù : ³»°ú, ¿µ»óÀÇÇаú, ¹æ»ç¼±Á¾¾çÇаú, º´¸®°ú      
Âü¼®¿¹»óÀοø : 250¸í
Èñ¸ÁÆòÁ¡ : 6Á¡  
Áö¿ª : ¼­¿ïƯº°½Ã
±³À°½Ã°£ : 6 ½Ã°£ 55ºÐ  
¼¼ºÎ¼ö°­·á : 80,000¿ø      
ºñ°í »çÀüµî·Ï : Àü¹®ÀÇ 50000¿ø ÀüÀÓÀÇ 30000 ¿ø ±âŸ 70000¿ø ´çÀϵî·Ï : Àü¹®ÀÇ 60000¿ø ÀüÀÓÀÇ 40000 ¿ø ±âŸ 80000¿ø      

±¸ºÐ ¿ùÀÏ °­ÀǽǠ½Ã°£ ±³À°Á¦¸ñ  °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 01-29 ÇѶó 09:00~09:25 Discoveries in metastasis biology and tumor microenvironment  ÀÌ´ë¿ø(¼­¿ïÀÇ´ë) 
±³À°½Ã°£ 01-29 ÇѶó 09:25~09:50 Immune landscape in breast cancer  ±è¹Îȯ(¿¬¼¼ÀÇ´ë) 
±³À°½Ã°£ 01-29 ÇѶó 09:50~10:15 Dynamic ctDNA and genomic profiles to monitor response prediction  ÀÌÁöÀº(°¡Å縯ÀÇ´ë) 
Åä·Ð 01-29 ÇѶó 10:15~10:30 Q & A  () 
È޽Ġ01-29 ÇѶó 10:30~10:45 Coffee break  () 
±³À°½Ã°£ 01-29 ÇѶó 10:45~11:10 AI applied to imaging and biopsy  TBD(TBD) 
±³À°½Ã°£ 01-29 ÇѶó 11:10~11:35 Optimal loco-regional surgical management : Reducing the impact of axillary surgery  ¹Ú¼¼È£(¿¬¼¼ÀÇ´ë) 
±³À°½Ã°£ 01-29 ÇѶó 11:35~12:00 Updates in Radiotherapy : Should one week of RT be standard of care?  ÀåÁö¼®(¿¬¼¼ÀÇ´ë) 
±³À°½Ã°£ 01-29 ÇѶó 12:00~12:25 Highlights of survivorship and lifestyle modification  °í¼öÁø(¿ï»êÀÇ´ë) 
Åä·Ð 01-29 ÇѶó 12:25~12:40 Q & A  () 
±³À°½Ã°£ 01-29 ÇѶó 12:40~13:10 TBD  ÀÓ¼®¾Æ(¼­¿ïÀÇ´ë) 
È޽Ġ01-29 ÇѶó 13:10~13:30 Coffee break  () 
±³À°½Ã°£ 01-29 ÇѶó 13:30~13:55 Optimal adjuvant endocrine treatment for HR+/HER2- EBC  ±èÇÑÁ¶(¼øõÇâÀÇ´ë) 
±³À°½Ã°£ 01-29 ÇѶó 13:55~14:20 Refining (neo)adjuvant immunotherapy and chemotherapy  ¹ÚÀÎÇý(°í·ÁÀÇ´ë) 
Åä·Ð 01-29 ÇѶó 14:20~14:30 Q & A  () 
È޽Ġ01-29 ÇѶó 14:30~14:45 Coffee break  () 
±³À°½Ã°£ 01-29 ÇѶó 14:45~15:10 Advanced in systemic treatment options for HER2+ ABC  ½É¼ºÈÆ(±¹¸³¾Ï¼¾ÅÍ) 
±³À°½Ã°£ 01-29 ÇѶó 15:10~15:35 Novel SERDs, CDK inhibitors and beyond in advanced HR+/HER- ABC  ±èÁöÇü(¿¬¼¼ÀÇ´ë) 
Åä·Ð 01-29 ÇѶó 15:35~15:45 Q & A  () 
±³À°½Ã°£ 01-29 ÇѶó 15:45~16:10 Therapeutic advances and new directions for TNBC  ¹Ú°æÈ­(°í·ÁÀÇ´ë) 
±³À°½Ã°£ 01-29 ÇѶó 16:10~16:35 New agents on the horizon  ÀÌ°æÀº(ÀÌÈ­ÀÇ´ë) 
Åä·Ð 01-29 ÇѶó 16:35~16:45 Q & A  () 
ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" ´ëÇÑÁ¾¾ç³»°úÇÐȸ Best of San Antonio Breast Cancer Symposium (SABCS) 2021 in Korea : 2022-01-29""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ¼öÁ¤ »èÁ¦
ÀÌÀü±Û °Ç°­º¸Çè ºòµ¥ÀÌÅÍ ÀÚ·áºÐ¼®À» ÅëÇÑ ³í¹®Ãâ°£ ¿öÅ©¼¥(2Â÷)(1ÀÏÂ÷) : 2022-02-04
´ÙÀ½±Û ´ëÇÑÇǺΰúÇÐȸ ºÎ»ê¿ï»ê°æ³² ÁöºÎȸ : 2022-01-28
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
20342 ¼­¿ï ¼­¿ï¾Æ»êº´¿ø (¿Â¶óÀÎ) 5¿ù 17ÀÏ ±Ý¿äÁý´ãȸ(¼Ò¾Æ À½¼º Àå¾Ö¿¡ ´ëÇÑ Á¢±Ù) : 2024-05-17 0 90 2024-04-03
20341 ´ë±¸ ´ëÇѽŻý¾ÆÇÐȸ Á¦31Â÷ Ãá°èÇмú´ëȸ : 2024-05-17 0 222 2024-04-03
20340 ¼­¿ï Çѱ¹½ÇÇèÇ÷¾×ÇÐȸ 2024 KSEH Spring Meeting – Revolutionizing technologies to overcome hurdles of cancer research & therapy : 2024-05-17 0 93 2024-04-03
20339 ¼­¿ï (¿Â¶óÀÎ) À̺ñÀÎÈÄ°ú Áö¿ªÀÇ»çÁý´ãȸ-GERDÀÇ ÃÖ½ÅÄ¡·á-°¡À̵å¶óÀÎÀ» Áß½ÉÀ¸·Î : 2024-05-16 0 101 2024-04-03
20338 ºÎ»ê ´ëÇÑÀçÈ°ÀÇÇÐȸ Á¦164Â÷ ºÎ»ê¿ï»ê°æ³²Áöȸ Áý´ãȸ : 2024-05-16 0 160 2024-04-03
20337 ¼­¿ï (¿Â¶óÀÎ) 2024³â ¼Ò¾Æ½ÅÀå Post-graduate education course : 2024-05-13 0 176 2024-04-03
20336 ¼­¿ï Çѱ¹ÀÓ»ó°íÇ÷¾ÐÇÐȸ 2024³â Ãá°èÇмú¼¼¹Ì : 2024-05-12 0 181 2024-04-03
20335 ¼­¿ï ´ëÇѼö¸é¿¬±¸ÇÐȸ °³¿øÀÇ ¡¤ ºÀÁ÷ÀÇ ¿¬¼ö±³À° : 2024-05-12 0 195 2024-04-03
20334 ¼­¿ï 2024³â ¼­Ãʱ¸ÀÇ»çȸ Ãá°è Çмú´ëȸ : 2024-05-12 0 110 2024-04-03
20333 Ãæ³² Á¦10ȸ ¼øõÇâ´ëÇб³ÀÇ°ú´ëÇРõ¾Èº´¿ø ¼ÒÈ­±â³»°úÇб³½Ç ¼ÒÈ­±âº´ ½ÉÆ÷Áö¿ò : 2024-05-11 0 146 2024-04-03
20332 ¼­¿ï ´ëÇÑÇ÷°ü¿Ü°úÇÐȸ : The 17th SMC Vascular Symposium, 2024 : 2024-05-11 0 147 2024-04-03
20331 ºÎ»ê Çѱ¹¿Ü°ú·Îº¿¼ö¼úÇÐȸ 2024 KAROS Ãá°èÇмú´ëȸ (2ÀÏÂ÷) : 2024-05-10 0 92 2024-04-03
20330 ¼­¿ï 2024 °Ç±¹´ëÇб³º´¿ø À̺ñÀÎÈÄ°ú °³¿øÀÇ Áý´ãȸ : 2024-05-09 0 80 2024-04-03
20329 ¼­¿ï (¿Â¶óÀÎ) À̺ñÀÎÈÄ°ú Áö¿ªÀÇ»çÁý´ãȸ-½Å°æÅ뼺 ÀÌÅëÀÇ Æ¯Â¡°ú ¾à¹°Ã³¹æ ¿ä·É, ¾à¹° ÁÖÀÇ»çÇ× : 2024-05-09 0 107 2024-04-03
20328 ºÎ»ê Çѱ¹¿Ü°ú·Îº¿¼ö¼úÇÐȸ 2024 KAROS Ãá°èÇмú´ëȸ (1ÀÏÂ÷) : 2024-05-09 0 183 2024-04-03
51 | 52 | 53 | 54 | 55 | 56 | 57 | 58 | 59 | 60
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷